HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia.

AbstractBACKGROUND:
In familial combined hyperlipidemia (FCHL) the severity of the dyslipidemia is determined by an overproduction of VLDL (very low density lipoprotein) particles and by its abnormal lipid composition. However, few are known regarding the metabolic factors that determine these abnormalities. We investigated the impact of metabolic factors on the number of atherogenic particles (apolipoprotein B level (apoB)) and the triglyceride content of very low-density lipoproteins (VLDLs-TG).
METHODS:
A cross-sectional study done in FCHL subjects and gender and age-matched healthy subjects. A clinical assessment, lipid profile and plasma concentrations of insulin, apolipoprotein CIII (apo CIII), apolipoprotein AII (apo AII), high sensitive C-reactive protein (HS-CRP), adiponectin and leptin were documented in 147 FCHL patients and 147 age-matched healthy subjects. Multivariate regression models were performed to investigate the independent determinants of VLDL-TG and apo B levels adjusting for confounding factors.
RESULTS:
The variables that determined the VLDL-triglyceride content as a surrogate of VLDL composition were apo CIII (β=0.365, p<0.001), insulin (β=0.281, p<0.001), Apo AII (β=0.145, p<0.035), and adiponectin levels (β=-0.255, p<0.001). This model explained 34% of VLDL composition (VLDL-TG) variability. However, none of these variables were independent contributors of apo B-containing particles.
CONCLUSIONS:
In patients with FCHL apo CIII, apo AII and adiponectin are major novel factors determining the VLDL particle composition. However, such factors do not explain apo B-containing particles.
AuthorsIvette Cruz-Bautista, Roopa Mehta, Javier Cabiedes, Cristina García-Ulloa, Luz Elizabeth Guillen-Pineda, Paloma Almeda-Valdés, Daniel Cuevas-Ramos, Carlos A Aguilar-Salinas
JournalClinica chimica acta; international journal of clinical chemistry (Clin Chim Acta) Vol. 438 Pg. 160-5 (Jan 01 2015) ISSN: 1873-3492 [Electronic] Netherlands
PMID25172037 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier B.V. All rights reserved.
Chemical References
  • Apolipoprotein C-III
  • Apolipoproteins B
  • Biomarkers
  • Lipoproteins, VLDL
  • Triglycerides
  • very low density lipoprotein triglyceride
Topics
  • Adult
  • Aged
  • Apolipoprotein C-III (blood)
  • Apolipoproteins B (blood)
  • Biomarkers (blood)
  • Case-Control Studies
  • Cohort Studies
  • Cross-Sectional Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Hyperlipidemia, Familial Combined (blood, diagnosis)
  • Lipoproteins, VLDL (blood)
  • Male
  • Middle Aged
  • Prognosis
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: